Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis | Zendy

T. Sonia Boender | Zendy; Kim Sigaloff | Zendy; James McMahon | Zendy; Sasisopin Kiertiburanakul | Zendy; Michael R. Jordan | Zendy; Jhoney Barcarolo | Zendy; Nathan Ford | Zendy; Tobias F. Rinke de Wit | Zendy; Silvia Bertagnolio | Zendy

Open Access

Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis

Author(s) -

T. Sonia Boender,

Kim Sigaloff,

James McMahon,

Sasisopin Kiertiburanakul,

Michael R. Jordan,

Jhoney Barcarolo,

Nathan Ford,

Tobias F. Rinke de Wit,

Silvia Bertagnolio

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ556

Subject(s) - medicine , antiretroviral therapy , confidence interval , meta analysis , human immunodeficiency virus (hiv) , viral load , pediatrics , demography , immunology , sociology

More than 11.7 million people are currently receiving antiretroviral therapy (ART) in low- and middle-income countries (LMICs), and focused efforts are needed to ensure high levels of adherence and to minimize treatment failure. Recently, international targets have emphasized the importance of long-term virological suppression as a key measure of program performance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research